Among these, alterations in the BRCA1-associated protein 1 (BAP1) gene are frequently identified in clear cell renal cell carcinoma (ccRCC) and have emerged as adverse prognostic and predictive biomarkers. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.